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ABSTRACT
The odds ratio (OR) is a measure of effect size commonly used in observational research.
OR reflects statistical association between a binary outcome, such as presence of a health
condition, and a binary predictor, such as an exposure to a pollutant. Statistical inference
and interval estimation for OR are often performed on the logarithmic scale, due to asymp-
totic convergence of log(OR) to normality. Here, we propose a new normalized measure of
effect size, γ′, and derive its asymptotic distribution. We show that the new statistic, based
on the γ′ distribution, is more powerful than the traditional one for testing the hypothesis
H0: log(OR)=0. The new normalized effect size is termed “gamma prime” in the spirit of
D′, a normalized measure of genetic linkage disequilibrium, which ranges from -1 to 1 for a
pair of genetic loci. The normalization constant for γ′ is based on the maximum range of the
standardized effect size, for which we establish a peculiar connection to the Laplace Limit
Constant. Furthermore, while standardized effects are of little value on their own, we pro-
pose a powerful application, in which standardized effects are employed as an intermediate
step in an approximate, yet accurate posterior inference for raw effect size measures, such
as log(OR) and γ′.
Keywords: gamma prime coefficient; posterior interval estimation; standardized coefficient
1
Odds ratio (OR) is an ubiquitous measure of effect size in medical and epidemiological re-
search. Among its useful properties is invariance across sampling designs (e.g., case-control
or prospective), and straightforward interpretation in terms of logistic regression coefficients.
Moreover, the log transformed odds ratios, log(OR), have analytically attractive properties,
for example, the asymptotic distribution of log(OR) rapidly converges to a normal distribu-
tion as the sample size increases. Given the estimated log of odds ratio, log(ÔR), a common
statistic used to assess significance of an association is:
Z =
log
(
ÔR
)
√
Var
(
log
(
ÔR
)) H0∼ Normal(0, 1) (1)
=
log
(
ÔR
)
√∑
1/nij
, (2)
where N =
∑
nij is the sum of the four cell counts in a 2 × 2 table. The total sample size
N can be factored out and the statistic can be re-expressed as:
Z =
√
N
log(ÔR)
σˆ
,
σˆ =
√
1
wˆ
1
pˆ(1− pˆ) +
1
1− wˆ
1
qˆ(1− qˆ) ,
where wˆ is the sample proportion of cases, pˆ is the estimated probability of exposure among
cases, and qˆ is the estimated probability of exposure among the controls. Thus, the asymp-
totically normal Z-statistic can be expressed as a product of the square root of the sample
size (
√
N) and the standardized log(OR) (δ) in the following way:
Z =
√
N × δˆ, δˆ = log(ÔR)
σˆ
.
In this paper, we derive the lower and the upper bounds on the possible values of the
standardized effect size γ = δmax(log(OR)) and show that γ can not exceed the Laplace
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Limit Constant (LLC). Although this result was previously stated by our group (1), details
and the derivation were never provided. Then, using the LLC as a normalizing constant,
we propose a new measure of the effect size, γ′ = γ/LLC, that is varying between -1 and 1.
We derive an asymptotic distribution of γ′ and show, via simulation experiments, that the
new association statistic based on the γ′ distribution is more powerful than the traditional
one based on Eq. (2). Finally, we show how the standardized log(OR) can be utilized to
accurately approximate posterior inference for the raw effect size, such as log(OR) and the
newly proposed γ′.
METHODS
Bounds for the standardized logarithm of odds ratio
We shall assume for now that epidemiological data is summarized by a 2×2 table as:
Exposure status
Disease status E E¯
D n11 = nDpˆ n12 = nD(1− pˆ)
D¯ n21 = nD¯qˆ n22 = nD¯(1− qˆ)
where n11 + n12 = nD is the number of cases; n21 + n22 = nD¯ is the number of controls;
and the number of exposed subjects is n11 + n21. When sampling is random with respect
to exposure, sample proportions pˆ = n11/nD and qˆ = n21/nD¯ are estimates of the population
probabilities of exposure among cases and among controls, respectively, p = Pr(E|D) and
q = Pr(E|D¯). Then, the effect of exposure on an outcome can be measured by the odds
ratio, OR, defined as:
OR =
p/(1− p)
q/(1− q)
=
Pr (E | D) [1− Pr (E | D¯)]
Pr
(
E | D¯) [1− Pr (E | D)] .
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To study influence of various risk factors on the outcome, one can test the null hypothesis H0 :
OR = 1, or equivalently H0: log(OR)=0. The logarithmic transformation is advantageous
because of the bounded and asymmetric nature of OR (it can not take negative values) and
also due to the fact that the distribution of log(OR) quickly converges to normality. Then,
the classical test statistic is defined as:
Z =
log
(
ÔR
)
√∑
1/nij
=
√
N
log(ÔR)
σˆ
, where σˆ =
√
1
wˆ
1
pˆ(1− pˆ) +
1
1− wˆ
1
qˆ(1− qˆ) ,
and wˆ is the sample proportion of cases, nD/N. The corresponding population parameter can
be written as:
σ2 =
1
w
1
p(1− p) +
1
(1− w)
1
q(1− q) . (3)
Conditionally on the value of OR, we can express variance (σ2) as a function of two variables
(w and p) to emphasize that the standard deviation (σ) will vary depending on the study
design and population prevalence of exposure among cases (we note that q can be expressed
in terms of p and OR as q = p/ [(1− p) OR +p]). Alternatively, conditionally on the observed
OR, one can express σ in terms of the exposure probability, v = Pr(E), and risk of disease
among exposed as:
σ2 =
1
v
1
Pr(D|E) [1− Pr(D|E)] (4)
+
1
1− v
1
Pr(D|E¯) [1− Pr(D|E¯)] ,
with Pr(D|E¯) = 1/(1−OR [1− 1/Pr(D|E)]).
To obtain maximum possible value of the standardized log(OR), we first need to minimize
σ, conditional on the OR value, with respect to its two parameters. For example, if we set the
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first partial derivative of Eq. (4) with respect to v to zero, and solve the resulting equation
in terms of Pr(D|E), it follows that:
vm = argmin
v
σ =
1
1 + RR
√
OR−1
. (5)
Further, setting the first partial derivative of Eq. (4) with respect to Pr(D|E) to zero and
plugging in vm instead of v results in
Pr(D|E) = 1− 1
1 +
√
OR
, (6)
and
Pr(D|E¯) = 1
1 +
√
OR
= 1− Pr(D|E). (7)
Now, substituting Eqs (6) and (7) into Eq. (5), we obtain v = 1/2. Similarly, operating with
Eq. (3), we can express the minimum w value in terms of p as
wm = argmin
w
σ =
1
1 + p
q
√
OR−1
, (8)
where q = p/ [(1− p) OR +p]. Then, we can obtain an equivalent expression for w as just
we did for v, w = 1/2. Using the conditional value of σ, the maximum standardized log(OR)
is
γ =
log(OR)
2
√
2 + 1+OR√
OR
. (9)
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Using the identity 1+OR√
OR
= 2 cosh
(
log(OR)
2
)
,
γ =
log(OR)
2
√
2
√
1 + cosh
(
log(OR)
2
) (10)
=
log(OR)
4 cosh
(
log(OR)
4
) . (11)
Equation (11) depends only on the logarithm of odds ratio, but it is not monotone in it: γ
reaches its maximum for log(OR) value at about 4.7987...,
γmax(log(OR) = 4.7987...) = 0.6627...
Surprisingly, as log(OR) exceeds that value, the corresponding normalized coefficient, γ,
starts to decrease. Further, although Equation (11) depends only on log(OR), its maximum
can only be attained at the specific values of population parameters. Namely, (a) v = w = 1/2,
(b) Pr(D|E¯) = 1 − Pr(D|E) from Eq.(7), which implies RR2 = OR, and (c) log(OR) =
4.7987..., which implies log(OR) = 121.354. . . and Pr(D|E) = Pr(E|D) = 0.9167782798 . . .
Connection to the Laplace Limit Constant
It turns out that there is an interesting connection between the expression for γmax and
the famous Kepler Equation (KE) for orbital mechanics, M = E − ε sin(E). Geometric
interpretations of M , E and ε are illustrated by Figure 1. Specifically, suppose that one is
inside a circular orbit, rescaled to be the unit circle, at the position S denoted by “?”. The
shortest path to the orbit has length 1 − ε. A celestial body traveles the orbit from that
point to point T. Given the area M/2 and distance 1 − ε, we want to determine the angle
E. These three values are related to one another by Kepler’s Equation. Planetary orbits are
elliptical, so the actual orbit is along an ellipse inside of the unit circle. Still, the calculation
of the eccentric anomaly, E, is a crucial step in determining planet’s coordinates along its
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elliptical orbit at various time points.
KE is transcendental, i.e., with no algebraic solution in terms of M and ε, and it has
been studied extensively since it is central to celestial mechanics. Colwell (2) notes that
“in virtually every decade from 1650 to the present” there have been papers devoted to
the Kepler Equation in the book suitably named “Solving Kepler’s Equation over three
centuries.” The solution to KE involves the condition equivalent to Eq. (11). Namely,
the solution can be expressed as the power series in ε, provided |ε sin(E)| < |E −M | and
that ε < ψ/ cosh(ψ), ψ = |E −M |, which is the “Laplace Limit Constant,” LLC (3). The
detailed mathematical derivation of the connection between Eq. (11) and LLC is provided
in “Supplemental Materials (S-1).”
The proposed normalized measure of effect size and its distribution
As we showed above, at any value of log(OR), the maximum of δ is
γ =
log(OR)
2
√
2 + (1 + OR)/
√
OR
.
The bounded nature of γ (ranging between −LLC and LLC) suggests a new normalized
measure of effect size, γ′ = γ/LLC, that has the range −1 ≤ γ′ ≤ 1. The new statistic
is appropriate as a measure of effect size where it is monotone in OR: within a very wide
range of odds ratios: 1/121 < OR < 121. For instance, Figure 2 shows that under the null
hypothesis, the relationship between log(OR) and γ′ is almost linear, and under the alterna-
tive hypothesis, the relationship is close to linear and monotone, as long as 1/121 < OR < 121
(these are rounded to integer OR values before the LLC maximum is reached).
Although γ′ is derived by using the range of the standardized log(OR), it is not a stan-
dardized measure in the same sense as scaling by a standard deviation. It is rather analogous
to a coefficient denoted by D′ (4), which is commonly used in genetics to measure association
between alleles at a pair of genetic loci (linkage disequilibrium, LD). D′ is akin to γ′ in the
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sense that a raw measure of LD is divided by its maximum value (which is a function of
allele frequencies) to yield the −1 ≤ D′ ≤ 1 range.
Using the first order Taylor series approximation, we derive an asymptotic variance of γ′,
as well as one- and two-sided asymptotic test statistics, as follows:
Var
(
γ̂′
)
= σˆ2
sech [log(ÔR)/4]
(
4− log
(
ÔR
)
tanh
[
log(ÔR)/4
])
16× LLC
2 .
T =
√
N
γ̂′√
Var
(
γ̂′
) ,
which simplifies to
T =
√
N
4 log
(
ÔR
)
σˆ
(
4− log
(
ÔR
)
tanh
[
log(ÔR)/4
]) . (12)
The asymptotic distributions for one- and two-sided statistics are
T
H0∼ Normal(0, 1),
T 2
H0∼ χ2(1),
where σˆ is defined as before:
σˆ =
√
1
wˆ
1
pˆ(1− pˆ) +
1
1− wˆ
1
qˆ(1− qˆ) .
We show by simulation experiments that the null distribution of this new statistic reaches
the asymptotic chi-square quicker than the commonly used X2 = log(ÔR)2/σˆ2 and that the
new statistic provides higher power under the alternative hypothesis.
We note that two other well-known transformations of the OR with the range from -1
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to 1 are Yule’s coefficients: Y =
√
OR−1√
OR+1
, the coefficient of colligation, and Q = OR−1
OR +1
(5).
Interestingly, using the identity
√
x−1√
x+1
= tanh (log(x)/4), the statistic T can be expressed as a
function of Y :
T =
√
N
4 log
(
ÔR
)
σˆ
(
Yˆ − 4
) . (13)
Further, note that 4 arctanh (Y) = 2 arctanh (Q) = log(OR). The arctanh transformation (to
log(OR)), known as Fisher’s variance stabilizing transformation (6), is expected to improve
the rate of asymptotic convergence to the normal distribution, thus we do not anticipate
that the asymptotic test statistics based Y and Q would be competitive when compared to
the Z statistic based on the log(OR). Nevertheless, we obtained approximate variances for
Y and Q using the first order Taylor series approximation (the same type of approximation
that yields the asymptotic variance for log(OR)) as follows:
V̂ar
(
Ŷ
)
=
1
N
 pˆ
wˆ(1− pˆ)qˆ2
(√
pˆ(1−qˆ)
(1−pˆ)qˆ + 1
)4 + 1− qˆ
(1− wˆ)(1− pˆ)2qˆ
(√
pˆ(1−qˆ)
(1−pˆ)qˆ + 1
)4
 ,
V̂ar
(
Q̂
)
=
1
N
[
4(1− pˆ)pˆ(qˆ − 1)2qˆ2
(1− wˆ)(pˆ+ qˆ − 2pˆ qˆ)4 −
4(pˆ− 1)2pˆ2(qˆ − 1)qˆ
wˆ(pˆ+ qˆ − 2pˆ qˆ)4
]
.
Via simulations, we confirmed that the statistic for Y tends to be more conservative and less
powerful than Z, while the statistic for Q is anti-conservative and reaches the nominal 5%
size only around N = 1000. However, these results are omitted here and we focus instead
on comparisons of statistics based on γ′ and log(OR).
Approximate Bayesian inference
The rationale for using standardized coefficients (e.g., standardized log odds ratio) as mea-
sures of effect size in epidemiologic studies has been questioned and it has been suggested
that standardized coefficients are insufficient summaries of effect size (7, 8). Nonetheless, we
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argue that the standardized effects can be utilized efficiently in their new application devel-
oped here, as tools for delivering approximate Bayesian inference. Specifically, we propose
to employ standardization as an intermediate step that yields posterior inference for param-
eters of interest (such as log(OR) or γ′). The key to this approach is the observation that
it is often straightforward to obtain an approximate posterior distribution for standardized
effects (δ = µ/σ) using a noncentral density as likelihood. Once such standardized posterior
distribution is estimated, it can be converted to an approximate posterior distribution for a
parameter of interest, µ.
Let ξ =
√
N × δ denote the noncentrality parameter of the raw effect size density (for
instance, Z ∼ N(ξ, 1) or X2 ∼ χ21(ξ)). To obtain an approximate posterior distribution, one
needs to specify a prior distribution for a raw measure of effect size, µ, as a binned frequency
histogram, with a finite mixture of values µ1, µ2, . . . , µB (the mid-values of bins) and the
corresponding probabilities, Pr(µi) (the height of bins as percent values). For example, if the
effect size is measured by µ=log(OR), such binned frequency histogram may be bell-shaped
with a sizable spike around zero, indicating that the majority of risk effects are anticipated to
be small. Alternatively, if the effect size is measured by log2(OR), the frequency histogram
may be L-shaped, with a spike of the mass again at about zero.
Next, we employ an approximation to a fully Bayesian analysis (which would have re-
quired a joint prior distribution for both µ and σ), and “dress” the raw parameter, by plug-
ging in the estimate of the standard deviation, to obtain values of δi = µi/σˆ and ξi =
√
Nδi.
Then, given the observed value of a test statistic T = t, the posterior distribution of the
standardized effect size will also be a finite mixture, calculated as:
Pr(ξj | T = t) = Pr(µj)f(T = t | ξj)∑B
i=1 Pr(µi)f(T = t | ξi)
, (14)
where f is the test statistic density with the non-centrality parameter ξi, i = 1, . . . , B. Once
the posterior distribution for the standardized effect size (times
√
N), is evaluated, one can
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approximate the posterior distribution for the raw parameter of interest by “undressing”
it, i.e., multiplying by the sample standard deviation and scaling by the square root of the
sample size. For example,
Pr(γ′i | T = t) = Pr
(
ξi ·
√
V̂ar
(
γ̂′
)
/
√
N | T = t
)
(15)
or
Pr(log(OR)i | T = t) = Pr
(
ξi ·
√
V̂ar
(
log(ÔR)
)
/
√
N | T = t
)
. (16)
From this approximate posterior distribution, one can then obtain an effect size estimator as
the posterior mean by taking a weighted sum (e.g., E(γ′ | T = t) = ∑Bi=1 γ′i Pr(γ′i | T = t)),
construct posterior credible intervals, etc. ‘Approximation’ here refers to approximating a
fully Bayesian modeling: our approach is a compromise between the frequentist and the
Bayesian methodologies due to the usage of plug-in frequentist estimates for certain pa-
rameters. Although the posterior distribution for the raw effect size is approximate (due
to plugging in a point sample estimate of the standard deviation), it is nevertheless highly
accurate, as we demonstrate through our simulation experiments.
RESULTS
Simulations: Frequentist properties
To investigate statistical properties of the proposed procedures in relation to the traditional
Z-test, we now turn to simulation experiments (the details of the simulation setup are
provided in “Supplemental Materials (S-2)”).
Our simulations are not intended to be comprehensive, and we specifically compared
only the two statistics discussed in this report. The comparison is ‘apples to apples,’ i.e.,
between two similarly derived Wald test statistics, both based on transformations of OR as
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a measure of effect size. The basic model for OR, without stratification or covariates, follows
from 2×2 contingency table, and we note that performance of different tests for contingency
table associations has been thoroughly investigated before (9, 10).
The Type-I error rates of the two tests, calculated under the null hypothesis of no effect,
log(OR) = 0, are shown in Table 1. For small number of cases, both statistical tests behave
conservatively, but the size of the test based on γ′ is considerably closer to the nominal
level of α = 0.05. As the number of cases increases, the size of both tests approaches the
nominal level. Table 2 shows statistical power of the two tests for the different combinations
of log(OR), its variance, and the number of cases. For all combinations of parameters
considered, the γ′-based test has higher statistical power than the Z-test, particularly for
small sample sizes.
We further note that the power of these two-sided tests can be investigated analytically
by plugging in the population parameters, p, q, w and considering the ratio of Z and T
values, Z/T . Sample size and variance cancel out and their ratio becomes only a function of
log(OR):
Z/T =
4− log(OR) tanh [log(OR)/4]
4
.
Figure 3 illustrates that for all odds ratio values within the (1/121−121) interval, T -statistics
are at least as large as Z-statistics. Under the null (true log(OR) = 0), the ratio Z/T is one,
and the two statistics are equivalent.
Simulations: Bayesian properties
Averaged across simulations, Table 3 reports (a) the true mean value of the raw parameter,
E(γ′), corresponding to the maximum observed test statistic; (b) the posterior expectation
E(γ′ | Zmax); (c) the average for the frequentist estimator of gamma prime, E(γ̂′); and
(d) the average probability to contain the true log(OR) value by the high posterior density
12
interval.
On the one hand, Table 3 shows that posterior expectation is very close to the true
average effect size value, even when posterior inference was performed using small sample
sizes and extreme selection (i.e., the top-ranking result taken out of one million statistical
tests). On the other hand, Table 3 illustrates that the frequentist estimator of γ′ is subject
to the winner’s curse and grossly exaggerates the true magnitude of effect size. Finally, after
comparing posterior convergence to the corresponding nominal levels, it is clear that the
posterior interval’s performance is satisfactory.
Real data application
To illustrate a practical implementation of the proposed effect size measure, we calculated
γ′ for six dietary intake risk factors associated with diabetes: whole grain (11), protein (12),
alcohol consumption (13), fruits and berries (14), dietary magnesium (15), and dietary cal-
cium (16). All reported associations used in this application reached nominal 5% statistical
significance. Reports that examinine individual dietary factors in relation to the type 2 dia-
betes (T2D) are inconclusive (17–19) and to check robustness of these results, we converted
the reported ORs to γ′’s and constructed posterior intervals for our new measure, assuming
three different a priori levels of belief that a reported dietary factor is truly a risk of T2D.
The a priori assumptions were set to (1) optimistic or 25% chance that the reported asso-
ciation is false, (2) even or 50% chance that the report is false, and (3) poor or 75% chance
that the report is false. For real associations, we assumed that there is 5% a priori chance
of encountering OR ≥ 2 (or OR ≤ 1/2). This is the same assumption as we made in our
simulations (S-2).
Table 4 summarizes our results. The first row of the table reports robustness of the
whole grain intake association with T2D. The initially published frequentist estimate OR
= 0.70 corresponds to the negative γ′ = −0.13, indicating that greater whole grain intake
may reduce risk of T2D (i.e., negative values of γ′ imply a protective effect). The posterior
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expectation of γ′ is similar to the frequentist estimate for all levels of a priori belief that the
effect is genuine. Furthermore, regardless of levels of uncertainty in the protective effect of
the whole grain, the upper bound of the 95% posterior interval did not cover 0, suggesting
that the effect might be real or at least strong enough statistically to withstand substantial
perturbations in prior assumptions.
The second row of Table 4 shows robustness of association between protein intake and
T2D. The initial OR = 1.16 corresponds to the positive value of γ′ = 0.06, suggesting
that higher intake of dietary protein is associated with an increased risk of T2D. Posterior
estimates for the dietary protein effect magnitude are not as high as the frequentist’s for all
levels of a priori belief that the effect is genuine, but maintain posterior ‘significance’ under
the optimistic a priori scenario (75% prior chance that the association is real). For the 50-50
or lower a priori chances, we can no longer conclude with confidence that dietary protein
intake is associated with an elevated risk of T2D.
The remaining rows of Table 4 report results for alcohol, fruits and berries, dietary
magnesium, and dietary calcium associations with T2D. At all levels of a priori skepti-
cism/optimism regrading the nature of the reported associations, the posterior intervals for
γ′ values cover zero, indicating that these findings do not have a strong statistical support.
It is useful to contrast posterior intervals with the frequentist (confidence) intervals, CIs.
None of the reported CIs, except for the dietary calcium association, cover zero. Can one
modify prior assumptions so that posterior intervals would match CIs? In other words, what
are the implicit prior assumptions that govern the width of CIs? It turns out that simply
lowering the prior pi0 = Pr(H0) from 25% to 0% is insufficient, and one also needs to assume a
substantially flatter distribution for chances of a true association. Specifically, to match the
endpoints of the reported CIs, one needs to assume a 5% a priori chance of encountering an
OR as large as 4 for dietary risk factors of T2D and simultaneously lower Pr(H0) to about
0.5%. Although such prior assumptions are often described as non-informative or vague,
they in fact correspond to a strong but unrealistic belief that observing large OR values is
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not much less likely than the small ones.
DISCUSSION
In this article, we propose a new powerful transformation of the odds ratio to measure the
magnitude of associations between risk factors and a binary outcome. The proposed test
statistic for γ′ has competitive power compared to the traditional statistic for testing the null
hypothesis that OR=1. Further, we introduce a simple and efficient approach for obtaining
an approximate posterior distribution for γ′ and demonstrate its robustness to selection bias,
a feature that aims to improve reliability of reported findings. Via simulations, we showed
that γ′-based test has better control of the Type I error rate over the traditional Z-test
for small sample sizes. The power of our method is always at least as good as that of the
traditional Z-test under the tested scenarios.
Our new measure γ′ is normalized by the Laplace Limit Constant to range between −1
and 1, yet it should not be regarded as an approximate transformation to a correlation
coefficient, nor does it behave as a standardized measure of effect size. That said, the usual
standardized log(OR) can be approximately related to the standardized slope and to the
correlation coefficient R = β × (σX/σY ) in simple linear regression models. When both X
and Y are binary, R can be expressed as:
R = (p− q)
√
w(1− w)√
v(1− v)
≈ ln(OR)
√
v(1− v)
√
w(1− w), (because p− q ≈ ln(OR)(1− v)v),
≈ δ.
Standardized coefficients may be used in practice as a “scale-free” measure, however it has
been suggested that their magnitude may not appropriately reflect relative importance of
explanatory variables (7, 8). Since our γ′ is not obtained using a regular standardization
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technique (i.e., scaling by the standard deviation), we omit arguments for and against the
use of standardized coefficients in statistical practice.
As we briefly discussed in the Methods Section, another two popular OR transforma-
tions with (-1, 1) range are Yule’s Y and Q coefficients. If one were to apply the arctanh
transformation to either Y or Q, the result would be equal to log(OR) times a constant.
Thus, it should be expected that statistics that are directly based on Y or Q, (without the
variance stabilizing transformation), would not be competitive to the one based on log(OR)
– the result that we confirmed via simulations. Curiously, although γ′ can be expressed
as a function of Y (see Eq (13)), statistical power of the γ′-test is higher than that of the
log(OR)-based test, in stark contrast to properties of test statistics directly based on sample
variances of Yule’s coefficients. We further note that the relationship between Yule’s coef-
ficients and log(OR) is monotonic for all values of log(OR), while the relationship between
γ′ and log(OR) is monotonic only for log(OR) values varying between about 1/121 and 121.
Nonetheless, although the range of log(OR) values admissible for γ′ transformation is limited
to this range, it covers the majority of plausible log(OR) values observed in practice.
We showed here how the standardized logarithm of odds ratio, δ, can be utilized as a
middle step towards an approximate posterior inference for a raw (non-standardized) pa-
rameter of interest. Assuming that the prior distribution for the raw parameter is known
precisely, we checked performance of our method in terms of its resistance to the winner’s
curse and robustness of estimation in the presence of multiple testing. Of course, exact
knowledge of the prior distribution is improbable, however it is a very useful assumption
to make for the purpose of checking the accuracy of methods performance in such an ideal
scenario. Assuming that the prior is known, proper posterior estimates should not overstate
the effect size when the top-ranking associations are selected out of a large number of results.
As for practical implementations, although the exact prior distribution may not be known,
it is possible for it to be specified realistically. We recognize that the problem of a reasonable
prior choice may be challenging, but also note that this problem is not unique to our method
16
and is ubiquitous within the Bayesian framework. Therefore, in practice, it is important to
assess robustness of posterior estimates to changes in prior parameters. For instance, in our
application, we varied the prior probability of encountering a true association and found that
the association between whole grain consumption and T2D was quite resilient to the increase
in the prior Pr(H0). The association between alcohol, fruits and berries, dietary magnesium
or calcium consumption and T2D, on the contrary, vanished even under optimistic prior
assumptions (75% chance) about the frequency of real effects.
Finally, we note that using the proposed methodology, the posterior estimates can be
calculated using only commonly reported statistics (such as log(OR) and its standard error),
without requiring access to individual records. Within the proposed framework, any arbitrary
prior distribution for a parameter that measures effect size can be easily accommodated in a
form of a binned frequency table. The discretized nature of the prior does not preclude usage
of continuous distributions, because modern statistical packages have facilities to finely chop
continuous density functions, thus enabling one to obtain arbitrarily accurate approximations
to continuous priors.
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Figure Legends
Figure 1: The Kepler equation: geometric interpretation. Given the knowledge of the area
M and the distance to the origin, ε, solve for the angle E in M = E − ε sin(E).(2)
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Figure 2: The relationship between log(OR) and γ′. The figure illustrates that under the
null hypothesis (log(OR) = 0), the relationship between sample values of log(OR) and γ′ is
approximately linear, and under the alternative hypothesis (log(OR) 6= 0) the relationship
is monotone in the interval 1/121 < OR < 121.
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Figure 3: The range of Z/T -ratio values for 1/121 < OR < 121. The red line highlights
log(OR) values, for which γ′-based T -statistic considerably exceeds Z-statistic. The blue
rectangular highlights log(OR) values near the null hypothesis, for which the two statistics
are similar to one another. Note that for all values of log(OR), Z-value never exceeds T -value.
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Tables
log(OR) γ′
nD = 25 0.0290 0.0508
nD = 50 0.0381 0.0501
nD = 100 0.0432 0.0494
nD = 250 0.0464 0.0491
nD = 500 0.0476 0.0490
nD = 1000 0.0485 0.0490
nD = 5000 0.0497 0.0498
Table 1: The Type-I error rate by the number of cases (log OR = 0).
log(OR) γ′ log(OR) γ′ log(OR) γ′ log(OR) γ′
log(OR)∼N(0, τ) ⇒ τ = log(2)
Φ−1(1−0.05) ≈ 0.42 τ = 0.5 τ = 1 τ = 2
nD = 25 0.065 0.098 0.080 0.116 0.212 0.263 0.441 0.493
nD = 50 0.121 0.142 0.151 0.174 0.358 0.385 0.602 0.624
nD = 100 0.204 0.217 0.253 0.266 0.503 0.516 0.718 0.726
nD = 250 0.360 0.365 0.423 0.429 0.664 0.668 0.821 0.823
nD = 500 0.490 0.493 0.553 0.556 0.757 0.758 0.873 0.874
nD = 1000 0.613 0.614 0.666 0.667 0.825 0.826 0.909 0.910
nD = 5000 0.814 0.814 0.843 0.843 0.921 0.921 0.960 0.960
Fixed OR ⇒ OR = 1.25 OR = 2 OR = 3 OR = 4
nD = 25 0.038 0.064 0.124 0.176 0.276 0.354 0.411 0.499
nD = 50 0.061 0.076 0.267 0.303 0.559 0.602 0.735 0.770
nD = 100 0.091 0.101 0.499 0.521 0.840 0.854 0.938 0.945
nD = 250 0.174 0.180 0.850 0.856 0.985 0.986 0.999 0.999
nD = 500 0.306 0.310 0.971 0.972 0.999 0.999 1 1
nD = 1000 0.532 0.534 0.998 0.998 1 1 1 1
nD = 5000 0.971 0.971 1 1 1 1 1 1
Table 2: Power of the tests by different levels of log(OR) and τ , assuming that
log(OR) ∼ N(0, τ).
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# of tests (L) n TrueE(γ′) E(γ′ | Zmax) E(γ̂′) Posterior coverage
10,000 500 0.46 0.46 0.55 94%
750 0.47 0.47 0.53 95%
1,000 0.48 0.48 0.52 95%
1,500 0.48 0.48 0.51 95%
100,000 500 0.52 0.53 0.62 93%
750 0.53 0.54 0.60 95%
1,000 0.54 0.55 0.60 95%
1,500 0.55 0.55 0.58 95%
500,000 500 0.56 0.57 0.67 92%
750 0.56 0.57 0.64 94%
1,000 0.58 0.58 0.63 94%
1,500 0.59 0.59 0.63 95%
1,000,000 500 0.58 0.59 0.69 91%
750 0.58 0.59 0.66 93%
1,000 0.61 0.61 0.66 95%
1,500 0.61 0.61 0.65 95%
Table 3: Average true value, E(γ′), average posterior estimator, E(γ′ | Zmax), and average
frequentist estimator, E(γ̂′), assuming γ′ ∼ N(0, τ = 0.42) for the top-ranking (maximum)
observed statistic (Z) selected out of L tests. Averages refer to the mean value taken across
simulation experiments
Dietary risk factor OR/γ′, 95%CI for γ′ Posterior expectation and interval for γ′
pi0 = 0.25 pi0 = 0.5 pi0 = 0.75
Whole grain intake (11) 0.70/-0.13, (-0.21, -0.06) -0.13 (-0.20, -0.05) -0.13 (-0.20, -0.05) -0.12 (-0.21, -0.03)
Protein intake(12) 1.16/0.06, (0.02, 0.09) 0.053 (0.01, 0.10) 0.05 (-0.00, 0.01) 0.04 (-0.00, 0.08)
Alcohol consumption(13) 1.67/0.19, (0.04, 0.34) 0.15 (-0.00, 0.29) 0.13 (-0.00, 0.27) 0.10 (-0.05, 0.26)
Fruits and berries(14) 0.69/-0.14, (-0.25, -0.03) -0.12 (-0.23, 0.00) -0.10 (-0.21, 0.00) -0.08 (-0.20, 0.04)
Dietary magnesium(15) 0.49/-0.26, (-0.47, -0.03) -0.17 (-0.34, 0.01) -0.15 (-0.32, 0.03) -0.11 (-0.30, 0.09)
Dietary calcium(16) 0.86/-0.06, (-0.11, 0.00) -0.043 (-0.10, 0.01) -0.03 (-0.09, 0.03) -0.01 (-0.08, 0.05)
Table 4: Posterior inference and robustness of results to prior assumptions: analysis of dietary risk
factors associated with type-II diabetes.
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Supplemental material
S-1 Connection to the Laplace Limit Constant (Continued)
To relate LLC to the bounds for standardized log(OR), let ψ = log(OR), ψ > 0. In terms
of ψ, the maximum of the standardized statistic is given by
γ = κ(ψ) = ψ
{
2
√
2 +
1 + exp (ψ)
exp (ψ/2)
}−1
. (S-1)
Using basic relations for hyperbolic functions:
1 + exp (ψ)
exp (ψ/2)
= 2 cosh (ψ/2) ,
2 +
1 + exp (ψ)
exp (ψ/2)
= 4 [cosh (ψ/4)]2 , and√
2 +
1 + exp (ψ)
exp (ψ/2)
= 2 cosh (ψ/4) ,
we can express κ(ψ) and its first derivative as
κ(ψ) = (ψ/4) {cosh (ψ/4)}−1 = (ψ/4) sech (ψ/4) (S-2)
κ′(ψ) =
4− ψ tanh (ψ/4)
16 cosh (ψ/4)
. (S-3)
To maximize the standardized log(OR), we need to set κ′(ψ) = 0, which is equivalent to
solving (ψ/4) tanh (ψ/4) = 1 for ψ. The solution is four times the solution to ψ tanh(ψ) = 1
equation, which is 1.19967864... This implies the maximum log(OR) = 4 × 1.1996... =
4.7987..., and by substituting this value into Eq. (11) we obtain γmax = 0.6627..., the LLC.
The solution to KE involves the condition equivalent to Eq. (11). Namely, the solution
can be expressed as the power series in ε, provided |ε sin(E)| < |E − M | and that ε <
ψ/ cosh(ψ), ψ = |E −M |, which is the LLC (3).
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S-2 Simulation Setup
We used simulations to compare performance of the asymptotic test based on the Z =
log(ÔR)√
V ar(log(ÔR))
statistic to the one based on the new statistic, γ′. For simulation i = 1, . . . , 106,
the true log(OR) was assumed to be either (a) fixed and equal to the same value across
simulations, or (b) normally distributed around zero with the standard deviation τ . The
parameter τ was chosen as τ = log(2)/Φ−1(1− 0.05) ≈ 0.42, that is, we assumed that there
is 5% a priori chance of encountering OR ≥ 2, and 5% chance of encountering OR ≤ 1/2.
The number of cases nD was (25, 50, 100, 250, 500, 1000, 5000) and the number of
controls was generated as nD¯ ∼ [Unif(1/2nD, nD)], where [·] is the nearest integer func-
tion. The probability of exposure among cases was drawn from a uniform distribution,
p ∼ Unif(0.05, 0.95), and the corresponding probability of expose among controls was cal-
culated as q = p/ [(1− p) OR +p]. Two-by-two table cell counts were obtained under the
binomal sampling with 1/2 added to each cell count:
n11 ∼ 1/2 + Binomial(nD, p),
n21 ∼ 1/2 + Binomial(nD¯, q),
n12 = 1/2 + nD − n11,
n22 = 1/2 + nD¯ − n21.
The addition of 1/2 to cell counts is known as the Haldane-Anscombe correction, commonly
used to improve asymptotic convergence to normality of the test statistic for log(OR) (20–
23). It can also be shown that after this correction, the resulting variance estimator,
Var
[
log(ÔR)
]
, approximates the posterior variance estimator derived assuming Jeffreys’
prior, i.e., Beta(1/2,1/2) prior distribution for p and q (24).
For studying Bayesian properties, simulated data sets were obtained as described above,
but with the following modifications. We sampled ψ = log(OR) from a prior mixture distri-
bution, where ψ was equal to zero with probability pi0 = Pr(H0) = 0.8, and with probability
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(1 − pi0), the values ψ were sampled as ψ ∼ Truncated Normal(0, t), discretized into 100
bins. The truncation parameter was set to t=4.8, which corresponds to the maximum OR
of about 121. In each simulation run (out of 10,000 in total for each setting), we performed
L = 104, 105, 5 × 105, or 106 tests and calculated posterior estimates for the top-ranking
result based on the largest value of a Z-statistic out of L tests.
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